Also, during the development of MS, there are type 2 helper T lymphocytes (Th2) that release anti-inflammatory ILs (IL-4, IL-5, IL10, and IL-13) that try to decrease the proinflammatory state. This evidence concerns the gene IL4 and myeloid sarcoma.